- Patent Title: Pharmaceutical composition comprising (1R,4R)-6′- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamol
-
Application No.: US16502651Application Date: 2019-07-03
-
Publication No.: US11311504B2Publication Date: 2022-04-26
- Inventor: Stefanie Frosch , Klaus Linz , Klaus Schiene
- Applicant: Gruenenthal GmbH
- Applicant Address: DE Aachen
- Assignee: Gruenenthal GmbH
- Current Assignee: Gruenenthal GmbH
- Current Assignee Address: DE Aachen
- Agency: Norris McLaughlin, P.A.
- Priority: EP12003897 20120518
- Main IPC: A61K31/167
- IPC: A61K31/167 ; A61K31/407 ; A61K31/223
![Pharmaceutical composition comprising (1R,4R)-6′- fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro [cyclohexane-1,1′-pyrano- [3,4,b ]indol] -4-amine and paracetamol or propacetamol](/abs-image/US/2022/04/26/US11311504B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to a pharmaceutical composition comprising a first pharmacologically active ingredient selected from (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and the physiologically acceptable salts thereof, and a second pharmacologically active ingredient selected from paracetamol and propacetamol.
Public/Granted literature
Information query